These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 32092504)

  • 1. Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis.
    M G; G DC; M F; M R; M C; C B; S A; G C; R F; C F; G C; M S; Cp Z
    Mult Scler Relat Disord; 2020 Jun; 41():102007. PubMed ID: 32092504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate uptake by oligodendrocytes: Implications for excitotoxicity in multiple sclerosis.
    Pitt D; Nagelmeier IE; Wilson HC; Raine CS
    Neurology; 2003 Oct; 61(8):1113-20. PubMed ID: 14581674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage.
    Vercellino M; Merola A; Piacentino C; Votta B; Capello E; Mancardi GL; Mutani R; Giordana MT; Cavalla P
    J Neuropathol Exp Neurol; 2007 Aug; 66(8):732-9. PubMed ID: 17882017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary progressive in contrast to relapsing-remitting multiple sclerosis patients show a normal CD4+CD25+ regulatory T-cell function and FOXP3 expression.
    Venken K; Hellings N; Hensen K; Rummens JL; Medaer R; D'hooghe MB; Dubois B; Raus J; Stinissen P
    J Neurosci Res; 2006 Jun; 83(8):1432-46. PubMed ID: 16583400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defective regulation of IFNgamma and IL-12 by endogenous IL-10 in progressive MS.
    Balashov KE; Comabella M; Ohashi T; Khoury SJ; Weiner HL
    Neurology; 2000 Jul; 55(2):192-8. PubMed ID: 10908889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease.
    Zoia C; Cogliati T; Tagliabue E; Cavaletti G; Sala G; Galimberti G; Rivolta I; Rossi V; Frattola L; Ferrarese C
    Neurobiol Aging; 2004 Feb; 25(2):149-57. PubMed ID: 14749132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutamate transporters of blood platelets as potential peripheral markers to analyze changes of glutamate transport activity in brain under altered gravity conditions.
    Borisova T; Kasatkina L
    J Gravit Physiol; 2007 Jul; 14(1):P81-2. PubMed ID: 18372710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurolymphatic biomarkers of brain endothelial inflammatory activation: Implications for multiple sclerosis diagnosis.
    Yun JW; Cvek U; Kilgore PCSR; Tsunoda I; Omura S; Sato F; Zivadinov R; Ramanathan M; Minagar A; Alexander JS
    Life Sci; 2019 Jul; 229():116-123. PubMed ID: 31082401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the tritium-labeled analog of L-threo-beta-benzyloxyaspartate binding to glutamate transporters.
    Shimamoto K; Otsubo Y; Shigeri Y; Yasuda-Kamatani Y; Satoh M; Kaneko S; Nakagawa T
    Mol Pharmacol; 2007 Jan; 71(1):294-302. PubMed ID: 17047096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin-stimulated glutamate uptake in human platelets is predominantly mediated by the glial glutamate transporter EAAT2.
    Hoogland G; Bos IW; Kupper F; van Willigen G; Spierenburg HA; van Nieuwenhuizen O; de Graan PN
    Neurochem Int; 2005 Dec; 47(7):499-506. PubMed ID: 16137792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis.
    Pampliega O; Domercq M; Villoslada P; Sepulcre J; Rodríguez-Antigüedad A; Matute C
    J Neuroimmunol; 2008 Mar; 195(1-2):194-8. PubMed ID: 18378006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
    Thouvenot E; Orsini M; Daures JP; Camu W
    Eur J Neurol; 2015 Mar; 22(3):564-9. PubMed ID: 25530281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CD40L expression on T CD4+ lymphocytes from peripheral blood in patients with relapsing-remitting and secondary progressive multiple sclerosis].
    Bilińska M; Frydecka I; Kosmaczewska A; Ciszak L; Koszewicz M; Pokryszko-Dragan A
    Pol Merkur Lekarski; 2006 Jan; 20(115):41-5. PubMed ID: 16617733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine profile, Foxp3 and nuclear factor-kB ligand levels in multiple sclerosis subtypes.
    Alatab S; Maghbooli Z; Hossein-Nezhad A; Khosrofar M; Mokhtari F
    Minerva Med; 2011 Dec; 102(6):461-8. PubMed ID: 22193377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased serum levels of soluble CD14 indicate stable multiple sclerosis.
    Lutterotti A; Kuenz B; Gredler V; Khalil M; Ehling R; Gneiss C; Egg R; Deisenhammer F; Berger T; Reindl M
    J Neuroimmunol; 2006 Dec; 181(1-2):145-9. PubMed ID: 17046070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression and function of glutamate transporters in multiple sclerosis.
    Vallejo-Illarramendi A; Domercq M; Pérez-Cerdá F; Ravid R; Matute C
    Neurobiol Dis; 2006 Jan; 21(1):154-64. PubMed ID: 16061389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of immunoregulatory T-helper cell subsets in patients with multiple sclerosis: relapsing-progressive course correlates with enhanced T H1, relapsing-remitting course with enhanced T H0 reactivity.
    Barth H; Klein K; Börtlein A; Guseo A; Berg PA; Wiethölter H; Klein R
    J Neuroimmunol; 2002 Dec; 133(1-2):175-83. PubMed ID: 12446020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirtuins and Metabolism Biomarkers in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis: a Correlation Study with Clinical Outcomes and Cognitive Impairments.
    Foolad F; Samadi-Bahrami Z; Khodagholi F; Nabavi SM; Moore GRW; Javan M
    Mol Neurobiol; 2024 Jun; 61(6):3442-3460. PubMed ID: 37995076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and cellular physiology of sodium-dependent glutamate transporters.
    Rose CR; Ziemens D; Untiet V; Fahlke C
    Brain Res Bull; 2018 Jan; 136():3-16. PubMed ID: 28040508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between LincR-Gng2-5'and LincR-Epas1-3'as with the severity of multiple sclerosis in Egyptian patients.
    Shaker OG; Golam RM; Ayoub S; Daker LI; Elguaad MKA; Said ES; Khalil MAF
    Int J Neurosci; 2020 May; 130(5):515-521. PubMed ID: 31790618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.